Clinical Trial Update: Reveal Chagas: Clinical Evidence of the Implantable Cardiac Monitor in Patients With Chagas Disease [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the Medtronic Reveal LINQ Insertable Cardiac Monitor in patients with Chagas disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chagas Disease

Drugs mentioned

• Reveal LINQ Insertable Cardiac Monitor

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Chagas Disease, Heart Diseases | Phase 4 | Status: TERMINATED